Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of LifeMD, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements about its competitive position and financial guidance during the specified class period [1]. Summary by Relevant Sections Allegations - The complaint claims that during the class period from May 7, 2025, to August 5, 2025, LifeMD's management overstated the company's competitive position [1]. - It is alleged that the company was reckless in raising its 2025 guidance without properly accounting for increasing customer acquisition costs in its RexMD segment and related to obesity treatment drugs like Wegovy and Zepbound [1]. - As a result, the statements made by the defendants regarding LifeMD's business operations and prospects were materially false and misleading [1]. Next Steps for Shareholders - Shareholders who purchased shares of LifeMD during the specified timeframe are encouraged to register for the class action by October 25, 2025 [2]. - Upon registration, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case [2]. Firm's Commitment - The Gross Law Firm is recognized for its commitment to protecting investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [3].

Core Viewpoint - The Gross Law Firm has announced a class action lawsuit against Flywire Corporation, alleging that the company made materially false and misleading statements regarding its revenue growth and the impact of permit and visa-related restrictions on its business [1][2]. Group 1: Allegations and Class Period - The class period for the lawsuit is from February 28, 2024, to February 25, 2025 [1]. - Allegations include overstating the strength and sustainability of Flywire's revenue growth and understating the negative impact of permit and visa-related restrictions on the business [1]. Group 2: Next Steps for Shareholders - Shareholders who purchased shares during the specified class period are encouraged to register for the class action by September 23, 2025 [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2]. Group 3: About The Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

Core Points - C3.ai, Inc. is facing a class action lawsuit due to allegations of providing misleading statements about its growth and the impact of its CEO's health on business operations [1][2] - The company announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to leadership reorganization and the CEO's health [1] - Following the announcement, C3.ai's stock price dropped approximately 25.58%, from $22.13 on August 8, 2025, to $16.47 on August 11, 2025 [1] Shareholder Information - Shareholders who purchased shares during the class period from February 26, 2025, to August 8, 2025, are encouraged to register for the class action and can do so without any cost or obligation [2] - The deadline for shareholders to seek lead plaintiff status is October 21, 2025 [2] Legal Representation - The Gross Law Firm is representing the shareholders and aims to protect investors' rights against deceit and fraud in business practices [3]

Core Viewpoint - Tronox Holdings plc is facing a class action lawsuit due to allegations of providing misleading statements about its financial health and sales forecasts, leading to a significant drop in stock price [2][3]. Group 1: Allegations and Financial Impact - The lawsuit claims that Tronox made overly positive statements while concealing material adverse facts about its commercial division and sales forecasts, which ultimately led to a decline in sales and increased costs [2]. - On July 30, 2025, Tronox reported a significant reduction in TiO2 sales, attributing the decline to a "softer than anticipated coatings season and heightened competitive dynamics," which resulted in a lowered full-year revenue guidance and a 60% reduction in dividends [2]. - Following the announcement, Tronox's stock price plummeted from $5.14 per share to $3.19 per share on July 31, 2025, marking a decline of approximately 38% in just one day [2]. Group 2: Class Action Details - Shareholders who purchased shares of Tronox during the class period from February 12, 2025, to July 30, 2025, are encouraged to register for the class action, with a deadline set for November 3, 2025 [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [3]. - The Gross Law Firm, which is leading the class action, emphasizes its commitment to protecting investors' rights against deceit and fraud [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Unicycive Therapeutics, Inc. regarding a class action lawsuit due to alleged misleading statements and failure to disclose critical information during the specified class period [1][2]. Summary by Relevant Sections Allegations - The complaint alleges that Unicycive Therapeutics overstated its readiness to meet FDA manufacturing compliance requirements, as well as the regulatory prospects of its oxylanthanum carbonate new drug application [1]. - It is claimed that the public statements made by the defendants were materially false and misleading throughout the class period from March 29, 2024, to June 27, 2025 [1]. Class Action Details - Shareholders who purchased shares of UNCY during the class period are encouraged to register for the class action, with a deadline set for October 14, 2025 [2]. - Participants will be enrolled in a portfolio monitoring software to receive updates on the case's progress [2]. Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit, fraud, and illegal business practices, emphasizing the importance of responsible business conduct [3]. - The firm seeks recovery for investors who suffered losses due to misleading statements or omissions that led to artificial inflation of stock prices [3].

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR). Shareholders who purchased shares of SMLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/semler-scientific-inc-loss-submission-form/?id=166133&from=3 CLASS PERIOD ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Nutex Health Inc. regarding a class action lawsuit due to allegations of misleading statements and fraudulent activities during a specified class period [1][3]. Group 1: Allegations - The complaint alleges that Nutex Health Inc. and its defendants made materially false and misleading statements and failed to disclose critical information during the class period from August 8, 2024, to August 14, 2025 [3]. - Specific allegations include that HaloMD, a third-party vendor, engaged in a scheme to defraud insurance companies, leading to unsustainable revenue for Nutex [3]. - The company is accused of overstating its remediation of material weaknesses in internal controls over financial reporting, which affected its ability to account for stock-based compensation obligations [3]. - As a result of these issues, Nutex improperly classified stock-based compensation obligations as equity instead of liabilities, increasing the risk of delays in filing financial reports with the SEC [3]. Group 2: Class Action Details - Shareholders who purchased shares of Nutex during the class period are encouraged to register for the class action, with a deadline set for October 21, 2025 [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [4]. - There is no cost or obligation for shareholders to participate in the case [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered losses due to deceit and fraud [5]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that inflate stock prices [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of PubMatic, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions that affected the company's stock value during a specified period [1][3]. Summary by Relevant Sections Class Action Details - The class period for the lawsuit is from February 27, 2025, to August 11, 2025 [3]. - Allegations include that PubMatic failed to disclose a significant shift of clients from a top demand side platform buyer to a new platform, leading to reduced ad spend and revenue [3]. Shareholder Actions - Shareholders are encouraged to register for the class action by October 20, 2025, to potentially be appointed as lead plaintiffs [4]. - Registration allows shareholders to receive updates on the case through portfolio monitoring software [4]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - The Gross Law Firm is notifying shareholders of LifeMD, Inc. regarding a class action lawsuit due to alleged misleading statements and failure to disclose critical information during a specified class period [1][3]. Group 1: Allegations - The complaint alleges that LifeMD's management materially overstated the company's competitive position [3]. - It is claimed that the defendants were reckless in raising LifeMD's 2025 guidance without properly accounting for rising customer acquisition costs in the RexMD segment and related to obesity treatment drugs like Wegovy and Zepbound [3]. - As a result, the statements made by the defendants regarding LifeMD's business, operations, and prospects were materially false and misleading [3]. Group 2: Class Action Details - The class period for the lawsuit is defined as May 7, 2025, to August 5, 2025 [3]. - Shareholders are encouraged to register for the class action by the deadline of October 25, 2025, to potentially be appointed as lead plaintiffs [4]. - Participation in the case does not incur any cost or obligation for the shareholders [4]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered due to deceit, fraud, and illegal business practices [5]. - The firm is committed to ensuring companies adhere to responsible business practices and engage in good corporate citizenship [5]. - The firm seeks recovery for investors who experienced losses due to false or misleading statements that led to artificial inflation of the company's stock [5].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Sable Offshore Corp. regarding a class action lawsuit due to alleged misleading statements made by the company during a specific period [1][4]. Class Period - The class period for the lawsuit is defined as from May 19, 2025, to June 3, 2025, which includes transactions related to the company's secondary public offering on May 21, 2025 [3]. Allegations - The complaint alleges that Sable Offshore Corp. falsely claimed to have restarted oil production off the coast of California, which was not the case. This misrepresentation led to materially false and misleading statements about the company's business and operations [4]. Deadline and Next Steps - Shareholders are encouraged to register for the class action by September 26, 2025, to participate in potential recovery. Registration will also provide access to portfolio monitoring software for status updates on the case [5]. Law Firm's Commitment - The Gross Law Firm emphasizes its mission to protect investors' rights against deceit and fraud, aiming to hold companies accountable for misleading practices that inflate stock prices [6].